Cell Therapy News Volume 11.15 | Apr 26 2010

    0
    46
    Cell Therapy News 11.15, April 26, 2010.
    In this issue:  Science  |  Policy  |  Business  |  NIH  |  CBER  |  Regulatory  |  Events Unsubscribe


    TOP STORY

    Gene Silencing may be Responsible for Induced Pluripotent Stem Cells' Limitations
    In a recent study, investigators describe finding that an important cluster of genes is inactivated in induced pluripotent stem cells that do not have the full development potential of embryonic stem cells. [Press release from EurekAlert! discussing online prepublication in Nature]

    HEMA 
    Become an expert at colony identification
    Hematopoietic Progenitor Assay Training Course
    by STEMCELL Technologies
     
     
    REGISTER HERESTEMCELL Technologies Inc
     

     

    SPECIAL FEATURE

    Complimentary Webinar Presented by STEMCELL Technologies

    Instructing Lineage Choice: Assays to Determine Effects of Cytokines and Novel Compounds on Hematopoiesis

    Thursday, May 13, 2010 at 9:00 a.m. EDT; 2:00 p.m. BST
    Ideal for participants in Europe

    Thursday, May 13, 2010 at 9:00 a.m. PDT
    Ideal for participants in North America

    More Information


    SCIENCE NEWS

    Tohoku University Team Discovers New Type of Stem Cells in Human Skin, Bone
    A research team from Tohoku University has discovered a new type of pluripotent stem cell in the skin and bone marrow of adults, providing a possible third source of stem cells after embryonic stem cells and human-made induced pluripotent stem cells. [Press release from The Mainichi Daily News discussing online prepublication in Proceedings of the National Academy of Sciences USA]

    An RNA Clue to Breast Cancer's Spread Clue
    Researchers may have found a new chink in the armor of breast cancer: a short stretch of RNA that can curb the growth of metastasized breast tumors in mice long after the cancers start growing. [Science Press Release]

    Scientist Grows Jaw Bone From Adult Stem Cells
    A Columbia scientist has become the first to grow a complex, full-size bone from human adult stem cells. [Press release from Columbia University discussing online prepublication in Proceedings of the National Academy of Sciences USA]

    Singapore Scientists’ Finding on Early Embryonic Development has Direct Impact on Regenerative Medicine and Assisted Reproduction
    Scientists have recently generated significant single cell expression data crucial for a detailed molecular understanding of mammalian development from fertilization to embryo implantation, a process known as the preimplantation period. [Press release from the Genome Institute of Singapore discussing online prepublication in Developmental Cell]

    Researchers Modify Virus to Hunt Down and Wipe Out Cancer Cells
    Researchers exploited the unique markers that appear on the surface of cancer cells to engineer a range of proteins that recognize and attach to these markers. These 'targeting' proteins can be added to a virus so that it recognizes and infiltrates cancer cells. [Press release from University of Leeds discussing online prepublication in Gene Therapy]

    Scientists Create Stem Cells from Eggs of Aging Mice
    Researchers have created stem cells from the eggs of aging mice that could be used for reproductive purposes and regenerative medicine. [Press release from New York University Langone Medical Center discussing online prepublication in Aging Cell]

    Body Builders – The Worms that Point the Way to Understanding Tissue Regeneration
    Scientists have discovered the gene that enables an extraordinary worm to regenerate its own body parts after amputation — including a whole head and brain. [Press release from The University of Nottingham discussing online prepublication in PLoS Genetics]

    Advanced Cell Technology’s Studies to Support Phase I Multicenter Trial of Patients with Stargardt’s Macular Dystrophy Demonstrate Excellent Safety Profile
    Advanced Cell Technology, Inc. announced that it has completed key animal studies in connection with its Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium cells to treat patients with Stargardt’s Macular Dystrophy, for which it filed an Investigational New Drug Application with the U.S. Food and Drug Administration in November. [Advanced Cell Technology, Inc. Press Release]

    StemCells, Inc. Plans to Advance to Second Clinical Trial in Batten Disease
    StemCells, Inc. announced that it has submitted a protocol to the Food and Drug Administration for initiation of a second clinical trial of its proprietary HuCNS-SC® human neural stem cells in neuronal ceroid lipofuscinosis, which is also often referred to as Batten disease. [StemCells, Inc. Press Release]

    The Food and Drug Administration Approves Stemedica Investigational New Drug Application for Ischemic Stroke Clinical Trial
    Stemedica Cell Technologies, Inc. announced that the U.S. Food and Drug Administration approved its application for an Investigational New Drug for a clinical trial for ischemic stroke using Stemedica's high potency proprietary allogeneic stem cells. [Stemedica Cell Technologies, Inc. Press Release]

    CURRENT PUBLICATIONSAberrant Silencing of Imprinted Genes on Chromosome 12qF1 in Mouse Induced Pluripotent Stem Cells
    By comparing genetically identical mouse embryonic stem cells and induced pluripotent stem cells (iPSCs), researchers show here that their overall messenger RNA and microRNA expression patterns are indistinguishable with the exception of a few transcripts encoded within the imprinted Dlk1–Dio3 gene cluster on chromosome 12qF1, which were aberrantly silenced in most of the iPSC clones. [Nature]

    Resolution of Cell Fate Decisions Revealed by Single-Cell Gene Expression Analysis from Zygote to Blastocyst
    Results illustrate the power of single-cell expression analysis to provide insight into developmental mechanisms. The technique should be widely applicable to other biological systems. [Dev Cell]

    Generation of Pluripotent Stem Cells from Eggs of Aging Mice
    These data demonstrate that eggs from old mice can generate pluripotent stem cells, and suggest that the isolation and in vitro culture of embryonic stem cells must select cells with high levels of DNA and telomere integrity, and/or with capacity to repair DNA and telomeres. [Aging Cell]

    Retargeted Adenoviral Cancer Gene Therapy for Tumor Cells Overexpressing Epidermal Growth Factor Receptor or Urokinase-Type Plasminogen Activator Receptor
    Investigators assessed the ability of bispecific fusion proteins to improve adenovirus-mediated transfer of therapeutic and marker transgenes. [Gene Ther]

    Knockdown of SOD1 Sensitizes the CD34+ CML Cells to Imatinib Therapy
    In this study, researchers found that the CD34+ subpopulation in the chronic myelogenous leukemia (CML) cell line K562 had a higher expression of SOD1 than that in the CD34 negative cells. [Med Oncol]

    Long Term Expansion of Undifferentiated Human Induced Pluripotent Stem and Embryonic Stem Cells in Suspension Culture Using a Defined Medium
    Researchers have applied human induced pluripotent stem cells (hiPS) expressing eGFP under control of the OCT4 promoter to establish the expansion of undifferentiated human embryonic stem and hiPS cells in suspension culture. [Stem Cell Res

    TeSR2_645x110_v01


    POLICY

    Michigan Senate Passes Stem Cell Regulation Package
    The Republican-led Senate passed a package of regulations critics say will place a chill on stem cell research in violation of the Michigan Constitution. [Michigan Senate, United States]

    Gubernatorial Candidates Talk Ways to Boost Bioscience
    Five gubernatorial candidates offered their prescriptions for creating a healthier climate for Minnesota's biotech industry that included lower taxes, higher government spending, and faith in science over ideology. [Minnesota, United States] 

    STEMSOFTBMTregistryad


    BUSINESS

    A Skeptic Questions Cancer Genome Projects
    Fueled by hundreds of millions of grant dollars, biomedical researchers have begun sequencing the genomes of thousands of tumor samples in the past few years, linking up scores of labs and sequencing centers in a massive effort to identify the genes behind major cancers. But a leading cancer geneticist questioned whether this strategy still makes sense. [Science Insider]

    Vatican Supports Stem Cell Initiative Led By University of Maryland School of Medicine
    Researchers at the University of Maryland School of Medicine are leading a new international research initiative, funded in part by the Vatican, to explore the therapeutic potential of intestinal stem cells. [University of Maryland School of Medicine Press Release]

    Silence Therapeutics and AstraZeneca Extend siRNA Delivery Collaboration
    Silence Therapeutics plc announces that the Company and AstraZeneca have agreed to a one-year extension of their ongoing small interfering RNA delivery collaboration. [Silence Therapeutics plc Press Release]

    Ontario's $11.5 Million will Build Network for Stem Cell-Based Therapies
    McMaster University's Stem Cell and Cancer Research Institute has received $11.5 million to lead a world-class initiative to develop new stem cell-based therapies. [McMaster University Press Release]

    NeoStem, Inc. and ImmuneRegen BioSciences® Announce a Collaborative Agreement to Advance Stem Cell Technology
    NeoStem, Inc. and ImmuneRegen Biosciences, Inc. announced that they have entered into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product. [PR Newswire]

    Florida Biotech Research Money in Jeopardy
    Florida researchers could lose $50 million in biomedical research funding due to the state’s $3 billion budget deficit. [Orlando Business Journal]

    Biotech Gets Lease Agreement Go-Ahead from Rochester Council
    The Rochester City Council approved a lease agreement at its regular meeting allowing the company to open a manufacturing facility on the third floor of the city's Minnesota Bioscience Center. [Post-Bulletin]

    Terrapin 2010 645 x110


    NIH

    Instructions for Completion and Technical Evaluation of the Vertebrate Animal Section (VAS) in NIH Contract Proposals (NOT-OD-10-049)

    Request for Information (RFI): Priorities for the NIH Adherence Research Network (NOT-OD-10-078)


    CBER

    Waivers for Conflicts of Interest for the May 7, 2010 Vaccines and Related Biological Products Advisory Committee Meeting


    REGULATORY

    FOOD AND DRUG ADMINISTRATION (United States)

    FDA Announces Draft Revised Guidance on Transparency and Advisory Committees

    Risk Communication Advisory Committee; Notice of Meeting [Docket No. FDA-2010-N-0001]

    Draft Guidance for the Public, Food and Drug Administration Advisory Committee Members, and Food and Drug Administration Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers; Availability [Docket No. FDA-2002-D-0094]


    EVENTS

    5th Canadian Symposium on Gene Therapy and Vaccines
    May 2-4, 2010
    Grenville-sur-la-Rouge, Canada

    Society for Biological Engineering's (SBE) 2nd International Conference on Stem Cell Engineering
    May 2-5, 2010
    Boston, United States

    Select BioSciences 4th Annual RNAi & miRNA World Congress
    May 5-7, 2010
    Boston, United States

    World Stem Cells & Regenerative Medicine Congress 2010
    May 11-13, 2010
    London, United Kingdom

    American Society of Gene & Cell Therapy (ASGCT) 2010 Clinical Trials Training Course and 13th Annual Meeting
    May 17-22, 2010
    Washington, DC, United States

    2010 Mater Medical Research Institute (MMRI) Stem Cell Symposium: Epigenetics, Transcriptomics and Nanobiotechnology of Stem Cells
    May 20-21, 2010
    Brisbane, Australia

    16th Annual International Society for Cellular Therapy (ISCT) Meeting
    May 23-26, 2010
    Philadelphia, United States

    ESTOOLS International Scientific Symposium: Stem Cells in Biology and Disease
    May 26-28, 2010
    Lisbon, Portugal

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – European Union 2010
    June 13-17, 2010
    Galway, Ireland

    International Society for Stem Cell Research (ISSCR) 8th Annual Meeting
    June 16-19, 2010
    San Francisco, United States

    XXXIst International Congress of the International Society of Blood Transfusion (ISBT) in joint cooperation with the 43rd Congress of the German Society for Transfusion Medicine and Immunohematology (DGTI)
    June 26-July 1, 2010
    Berlin, Germany

    United Kingdom National Stem Cell Network (UKNSCN) 3rd Annual Scientific Conference
    July 12-14, 2010
    Nottingham, United Kingdom

    2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2)
    August 2-4, 2010
    Singapore City, Singapore

    Select BioSciences 3rd Annual Stem Cells Europe Conference
    August 24-25, 2010
    Edinburgh, Scotland

    International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting
    September 11-14, 2010
    Belgirate, Italy

    Hydra VI: The European Summer School on Stem Cells & Regenerative Medicine
    September 11-17, 2010
    Hydra, Greece

    Stem Cells USA & Regenerative Medicine Congress 2010
    September 13-15, 2010
    Philadelphia, United States

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
    September 15-17, 2010
    Sydney, Australia

    2010 World Stem Cell Summit
    October 4-6, 2010
    Detroit, United States

    5th World Congress on Preventive & Regenerative Medicine (WCRM)
    October 5-7, 2010
    Hannover, Germany

    American Association of Blood Banks (AABB) Annual Meeting & Cellular Therapy and Transfusion Medicine Expo (CTTXPO) 2010
    October 9-12, 2010
    Baltimore, United States3rd Annual Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM)
    October 26-27, 2010
    Dubai, United Arab Emirates

    World Stem Cells & Regenerative Medicine Congress Asia 2010
    October 26-29, 2010
    Singapore City, Singapore

    Fraunhofer Life Science Symposium 2010
    October 29-30, 2010
    Leipzig, Germany

    Stem Cell Network 10th Annual Scientific Meeting
    November 22-24, 2010
    Calgary, Canada

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
    December 5-8, 2010
    Orlando, United States

    Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


     

    JOB OPPORTUNITIES

    Manager/Sr. Manager, Therapeutic Cell Solutions, Process Development (Lonza)

    Sr. Product Support and Training Specialist (CardianBCT)

    Recruit Top Talent
    Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
    Visit
    here to post your career opportunities.


     Learn more about Cell Therapy News:  Archives  |  Events  |  Update Profile  |  Contact Us